Defj, LLC
CIK: 0002147448
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNAZ
Transcode Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About DEFJ, LLC
DEFJ, LLC (SEC CIK 0002147448) files insider reports with the SEC as 10% Owner of Transcode Therapeutics, Inc. (RNAZ).
Signal8 holds 2 ownership filings by DEFJ, LLC (1 Form 3, 1 Form 4), filed on Aug 5, 2026. Those filings report 2 transactions, the latest on Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DEFJ, LLC's filings is in CENTRAL HONG KONG.
Recent filings by DEFJ, LLC
- Aug 3, 2026: Conversions of RNAZ shares (2 lines, Form 4, code C).
Other insiders filing for Transcode Therapeutics, Inc. (RNAZ)
- Tattory John A, Interim CFO
- Fitzgerald Thomas A, Chief Financial Officer
- CZEREPAK ELIZABETH, Director
- STOVER JACK E, Director